Improvements in Survival and Clinical Benefit With Gemcitabine as First-Line Therapy for Patients With Advanced Pancreas Cancer: A Randomized Trial.

Saved in:
Bibliographic Details
Title: Improvements in Survival and Clinical Benefit With Gemcitabine as First-Line Therapy for Patients With Advanced Pancreas Cancer: A Randomized Trial.
Authors: Burris HA 3rd; Institute for Drug Development, Cancer Therapy and Research Center, San Antonio, TX 78245, USA., Moore MJ; Institute for Drug Development, Cancer Therapy and Research Center, San Antonio, TX 78245, USA., Andersen J; Institute for Drug Development, Cancer Therapy and Research Center, San Antonio, TX 78245, USA., Green MR; Institute for Drug Development, Cancer Therapy and Research Center, San Antonio, TX 78245, USA., Rothenberg ML; Institute for Drug Development, Cancer Therapy and Research Center, San Antonio, TX 78245, USA., Modiano MR; Institute for Drug Development, Cancer Therapy and Research Center, San Antonio, TX 78245, USA., Cripps MC; Institute for Drug Development, Cancer Therapy and Research Center, San Antonio, TX 78245, USA., Portenoy RK; Institute for Drug Development, Cancer Therapy and Research Center, San Antonio, TX 78245, USA., Storniolo AM; Institute for Drug Development, Cancer Therapy and Research Center, San Antonio, TX 78245, USA., Tarassoff P; Institute for Drug Development, Cancer Therapy and Research Center, San Antonio, TX 78245, USA., Nelson R; Institute for Drug Development, Cancer Therapy and Research Center, San Antonio, TX 78245, USA., Dorr FA; Institute for Drug Development, Cancer Therapy and Research Center, San Antonio, TX 78245, USA., Stephens CD; Institute for Drug Development, Cancer Therapy and Research Center, San Antonio, TX 78245, USA., Von Hoff DD; Institute for Drug Development, Cancer Therapy and Research Center, San Antonio, TX 78245, USA.
Source: Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2023 Dec 20; Vol. 41 (36), pp. 5482-5492.
Publication Type: Clinical Trial; Research Support, Non-U.S. Gov't; Journal Article
Journal Info: Publisher: American Society of Clinical Oncology Country of Publication: United States NLM ID: 8309333 Publication Model: Print Cited Medium: Internet ISSN: 1527-7755 (Electronic) Linking ISSN: 0732183X NLM ISO Abbreviation: J Clin Oncol Subsets: MEDLINE; PubMed not MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1527-7755
DOI:10.1200/JCO.22.02777